Abstract
Melamine (2,4,6-triamino-1,3,5-triazine) was first synthesized by Liebig in 1834 and its industrial application, starting with the development of melamine formaldehyde resins in the late 1930ies, has boomed since. In the last 80 years a vast number of different melamine derivatives have been prepared in order to provide structures for applications such as polymers, medicinal drugs, or biologically active compounds. It is the purpose of this review to give an overview on the currently available melamine derivatives and the synthesis strategies leading to their formation.
Keywords: Cyanuric chloride, Melamine, Melamine derivatives, Synthesis, s-Triazines, Triamino-s-triazine
Current Organic Synthesis
Title:Melamine Derivatives - A Review on Synthesis and Application
Volume: 9 Issue: 3
Author(s): Klaus Bretterbauer and Clemens Schwarzinger
Affiliation:
Keywords: Cyanuric chloride, Melamine, Melamine derivatives, Synthesis, s-Triazines, Triamino-s-triazine
Abstract: Melamine (2,4,6-triamino-1,3,5-triazine) was first synthesized by Liebig in 1834 and its industrial application, starting with the development of melamine formaldehyde resins in the late 1930ies, has boomed since. In the last 80 years a vast number of different melamine derivatives have been prepared in order to provide structures for applications such as polymers, medicinal drugs, or biologically active compounds. It is the purpose of this review to give an overview on the currently available melamine derivatives and the synthesis strategies leading to their formation.
Export Options
About this article
Cite this article as:
Bretterbauer Klaus and Schwarzinger Clemens, Melamine Derivatives - A Review on Synthesis and Application, Current Organic Synthesis 2012; 9 (3) . https://dx.doi.org/10.2174/157017912801270612
DOI https://dx.doi.org/10.2174/157017912801270612 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell Death and microRNAs in Cholestatic Liver Diseases: Update on Potential Therapeutic Applications
Current Drug Targets Highlights on Medical Treatment of Uterine Fibroids
Current Pharmaceutical Design The Anti-Breast Cancer Effects of Green-Synthesized Zinc Oxide Nanoparticles Using Carob Extracts
Anti-Cancer Agents in Medicinal Chemistry Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Stem Cells Derived from Human Exfoliated Deciduous Teeth (SHED) in Neuronal Disorders: A Review
Current Stem Cell Research & Therapy The Daphniphyllum Alkaloids
Current Organic Chemistry Aryltetralin Lignans: Chemistry, Pharmacology and Biotransformations
Current Medicinal Chemistry Design, Synthesis and Biochemical Evaluation of Estrogen Receptor Ligand Conjugates as Tumour Targeting Agents
Letters in Drug Design & Discovery HCV-Related Rheumatic Manifestations and Therapeutic Strategies
Current Drug Targets Physiological and Non-Redundant Functions of PKC Isotypes in T Lymphocytes
Current Immunology Reviews (Discontinued) Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance
Current Neuropharmacology Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Landmark Studies of Targeted Therapies for Advanced Non-Small Cell Lung Cancer: A Guide for Pulmonologists
Current Respiratory Medicine Reviews De Novo Malignancies After Organ Transplantation: Focus on Viral Infections
Current Molecular Medicine Stromal Cell Derived Factor-1 / CXCL12, CXCR4 and CD26 in the Mobilization and Homing of Hematopoietic Stem and Progenitor Cells
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science Small-Animal Molecular Imaging for Preclinical Cancer Research: μPET and μSPECT
Current Radiopharmaceuticals Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
Current Drug Targets The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Current Bioactive Compounds